Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study.

"Declarations Conflict of interestThe authors declare no conflicts of interest. Informed consentInformed consent was obtained from all individual participants included in the study.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approvalThe SECA 1 and 2 studies were open prospective studies approved by the ethical board and registered at ClinicalTrials.gov with registration number NCT01311453 for the SECA-1 and NCT01479608 for the SECA-2 study. Conflict of interest The authors declare no conflicts of interest."

"Funding Open access funding provided by Vestre Viken Hospital Trust. The funding was supported by Vestre Viken Hospital Trust, Oslo University Hospital and The Norwegian Cancer Society."

"The SECA studies were approved by the Regional Ethics Committee and registered at clinicaltrials.gov with registration number NCT01311453 for the SECA-1 study and NCT01479608 for the SECA-2 study. All patients signed an informed written consent. Declarations: Conflict of interestThe authors declare no conflicts of interest.: Informed consentInformed consent was obtained from all individual participants included in the study.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.: Ethical approvalThe SECA 1 and 2 studies were open prospective studies approved by the ethical board and registered at ClinicalTrials.gov with registration number NCT01311453 for the SECA-1 and NCT01479608 for the SECA-2 study. Ethical approval: The SECA 1 and 2 studies were open prospective studies approved by the ethical board and registered at ClinicalTrials.gov with registration number NCT01311453 for the SECA-1 and NCT01479608 for the SECA-2 study."